PokeAcell
Personalized T cell therapy for solid tumors
Personalized T cell therapy for solid tumors
PokeAcell is an immunotherapy company with a proprietary technology for personalized T cell therapy of late stage cancer. PokeAcells proprietary technology activate and grow cancer-specific T cells present in patient’s own blood and the cells are given back to the patient as fully personalized treatment. The T cell therapy hold the promise of curative treatment in Metastatic Melanoma and Merkel Cell carcinoma – two of the most severe skin cancers today and with potential in several other indications.
There is no investment information
No recent news or press coverage available for PokeAcell.
We care about your data, and we'd love to use cookies make your experience better.
